Omdia is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Andrew Brosnan

Principal Analyst, AI Applications in Life Sciences

Oxford, UK

Andrew is a principal analyst in Omdia’s AI & Intelligent Automation practice, with a vertical focus of AI use cases and AI business impact, primarily in healthcare and financial services.

Based in Oxford, his career of 30 years spans the professional and financial services and life sciences sectors as an IT practitioner, industry analyst, and consultant. Andrew has worked in IT for multinational organizations such as JP Morgan and Merck Pharmaceuticals and as an industry analyst and market researcher for Grant Thornton and Goldman Sachs in corporate finance and investment banking, respectively. As an industry analyst, Andrew has advised enterprises on digital transformation to improve operational efficiency, IT product selection, business case development, best practice, IT strategy, and implementation. Andrew advises tech companies on product strategy and development, competitive intelligence, use cases, corporate development strategy, and go-to-market messaging. Andrew holds a bachelor’s degree in economics from Boston University and an MBA from the University of Warwick.

Follow Analyst
Latest View All

Quantum Computing in the Life Sciences – 2023

Subscription Required

Healthcare AI Maturity and AI Budget Survey Analysis – 2023

Subscription Required

Federated and Swarm Learning in Healthcare

Subscription Required

Generative AI Use Case Concordance – 1H23

Subscription Required

Generative AI: Market Landscape 2023

Subscription Required

2023 Trends To Watch: AI in Healthcare

Subscription Required